A recruitment follow-up SLA should define how quickly each handoff is reviewed, who owns the next step, and when stale work is escalated before patient interest loses momentum.
In this guide
Key points
- Follow-up SLAs work best when they separate first response, prescreen review, records readiness, scheduling, and stale-lead escalation.
- The SLA should create owner and due-date clarity without implying medical eligibility or guaranteed screening.
- Weekly review should compare SLA misses by source, study, site, owner, blocker, and next action.
Start with the moments where interest stalls
A clinical trial recruitment SLA should be built around handoffs, not abstract speed. The highest-risk points are usually first response, prescreen completion, coordinator review, records request, scheduling readiness, and stale-lead follow-up.
The goal is not to promise that every patient will screen or enroll. The goal is to make sure every patient inquiry has a clear owner, a timely next action, and a respectful close-out path when the study team determines the person should not continue.
Use practical SLA windows
A simple first version can set expectations like same-business-day ownership for new inquiries, one business day for first outreach, two business days for prescreen review after completion, two business days for records-request review, and a weekly stale-lead sweep.
Teams should adjust those windows by study complexity, staffing, visit burden, and source type. A high-touch referral source may need a different response expectation than a broad digital campaign, but both should still produce visible owner and next-action fields.
Define what counts as meaningful movement
A status update is not always meaningful movement. Useful movement includes first outreach attempted, patient responded, prescreen completed, records requested, records received, coordinator review completed, scheduling-ready, scheduled, closed as no response, or closed for an operational reason.
That definition keeps the SLA honest. If a lead is touched but no next action, due date, or owner changes, the team may still have a stale recruitment problem.
Review misses without blaming the queue
An SLA miss should start a workflow review. Was the issue source quality, coordinator capacity, missing records, unclear fit signals, scheduling constraints, or a patient who stopped responding? The answer decides the fix.
The weekly review should group misses by source, site, study, owner, blocker, and next action. That lets a site lead improve the workflow while keeping patient-specific details in the appropriate secure workspace.
Keep study-team boundaries clear
Follow-up SLAs should never imply that a patient is eligible, suitable, or guaranteed a screening visit. They only define the operational rhythm for reviewing interest and moving the next step forward when appropriate.
TrialsNest supports this kind of workflow by keeping source, owner, prescreen state, records readiness, stale risk, and next action visible. Authorized study teams still make final screening, eligibility, and enrollment decisions.
Sources and editorial notes
Published .
Written for recruitment operations teams setting follow-up expectations. It is workflow education only and does not replace study-team review or patient-specific decisions.
This guide explains recruitment work and questions to discuss with your team.
This information is educational. Your study team makes medical, eligibility, and enrollment decisions.
See TrialsNest in action
Bring this workflow into one place.
Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.
Coordinator Today
Your inquiries, priorities, and upcoming visits.
- Inquiries assigned
- 14 3 pending review
- Visits today
- 6 4 in person · 2 virtual
- Action priorities
- 4 Needs attention
- Active studies
- 3 Study A · B · C
Priority tasks
- Review screening intakeInquiry 001 · Study ACompleted
- Verify specimen preparationStudy A · Due 10:00 AMCompleted
- Confirm visit windowInquiry 003 · Follow-upPending
Upcoming visits
- In personInquiry 001
Study A · Baseline visit
View visit details → - TelehealthInquiry 003
Study A · Prescreen
Review appointment → - In personInquiry 004
Study B · Week 4
View visit details →
Keep reading
Research site recruitment follow-up cadence checklist
A research site checklist for clinical trial recruitment follow-up cadence, including first outreach, reminders, records requests, stale-lead review, and close reasons.
Clinical trial recruitment pricing questions for research sites
Pricing questions research sites can use when evaluating clinical trial recruitment software, services, source quality, reporting, and implementation effort.
Clinical trial recruitment software resources
Resources for teams comparing clinical trial recruitment software, patient recruitment software, dashboards, workflow coverage, implementation plans, and ROI.
Patient recruitment software ROI worksheet for research sites
ROI is not only more leads. For many sites, the first value is less wasted coordinator time and clearer movement from interest to scheduled next step.
